Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 2
1996 1
1997 6
1998 5
1999 3
2000 4
2001 3
2002 4
2003 8
2004 7
2005 12
2006 6
2007 9
2008 10
2009 10
2010 5
2011 12
2012 13
2013 13
2014 14
2015 10
2016 11
2017 24
2018 20
2019 11
2020 20
2021 23
2022 20
2023 15
2024 19
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

281 results

Results by year

Filters applied: . Clear all
Page 1
[Amyloidosis].
Hegenbart U, Farid KMN, Schönland S. Hegenbart U, et al. Dtsch Med Wochenschr. 2024 Oct;149(21):1270-1275. doi: 10.1055/a-2278-7742. Epub 2024 Oct 9. Dtsch Med Wochenschr. 2024. PMID: 39384208 German.
[Light chain amyloidosis].
Hegenbart U, Aus dem Siepen F, Schönland S. Hegenbart U, et al. Inn Med (Heidelb). 2023 Sep;64(9):842-847. doi: 10.1007/s00108-023-01568-0. Epub 2023 Aug 4. Inn Med (Heidelb). 2023. PMID: 37540260 Review. German.
Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis.
Muchtar E, Dispenzieri A, Wisniowski B, Palladini G, Milani P, Merlini G, Schönland S, Veelken K, Hegenbart U, Geyer SM, Kumar SK, Kastritis E, Dimopoulos MA, Liedtke M, Witteles R, Sanchorawala V, Szalat R, Landau H, Petrlik E, Lentzsch S, Coltoff A, Bladé J, Cibeira MT, Cohen O, Foard D, Wechalekar A, Gertz MA. Muchtar E, et al. Among authors: hegenbart u. J Clin Oncol. 2023 Mar 1;41(7):1393-1403. doi: 10.1200/JCO.22.00643. Epub 2022 Oct 10. J Clin Oncol. 2023. PMID: 36215675 Free PMC article.
Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series.
Forgeard N, Elessa D, Carpinteiro A, Belhadj K, Minnema M, Roussel M, Huart A, Javaugue V, Pascal L, Royer B, Talbot A, Gounot R, Hegenbart U, Schonland S, Karlin L, Harel S, Kastritis E, Bridoux F, Jaccard A, Arnulf B. Forgeard N, et al. Among authors: hegenbart u. Blood. 2024 Feb 22;143(8):734-737. doi: 10.1182/blood.2023022937. Blood. 2024. PMID: 38096365 Free article. No abstract available.
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes.
Palladini G, Dispenzieri A, Gertz MA, Kumar S, Wechalekar A, Hawkins PN, Schönland S, Hegenbart U, Comenzo R, Kastritis E, Dimopoulos MA, Jaccard A, Klersy C, Merlini G. Palladini G, et al. Among authors: hegenbart u. J Clin Oncol. 2012 Dec 20;30(36):4541-9. doi: 10.1200/JCO.2011.37.7614. Epub 2012 Oct 22. J Clin Oncol. 2012. PMID: 23091105
Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy.
Chakraborty R, Zanwar S, Hegenbart U, Bhutani D, Gertz MA, Dispenzieri A, Kumar S, D'Souza A, Patwari A, Cowan A, Chen G, Milani P, Palladini G, Sanchorawala V, Bodanapu G, Schönland SO, Lentzsch S, Muchtar E. Chakraborty R, et al. Among authors: hegenbart u. Blood. 2024 Dec 19;144(25):2613-2624. doi: 10.1182/blood.2024025899. Blood. 2024. PMID: 39197073
Prognosis and Staging of AL Amyloidosis.
Dittrich T, Kimmich C, Hegenbart U, Schönland SO. Dittrich T, et al. Among authors: hegenbart u. Acta Haematol. 2020;143(4):388-400. doi: 10.1159/000508287. Epub 2020 Jun 22. Acta Haematol. 2020. PMID: 32570242 Review.
Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis.
Muchtar E, Wisniowski B, Geyer S, Palladini G, Milani P, Merlini G, Schönland S, Veelken K, Hegenbart U, Leung N, Dispenzieri A, Kumar SK, Kastritis E, Dimopoulos MA, Liedtke M, Ulloa P, Sanchorawala V, Szalat R, Dooley K, Landau H, Petrlik E, Lentzsch S, Coltoff A, Bladé J, Cibeira MT, Cohen O, Foard D, Gillmore J, Lachmann H, Wechalekar A, Gertz MA. Muchtar E, et al. Among authors: hegenbart u. JAMA Oncol. 2024 Oct 1;10(10):1362-1369. doi: 10.1001/jamaoncol.2024.2629. JAMA Oncol. 2024. PMID: 39088206 Free PMC article.
Cryo-EM structure of a lysozyme-derived amyloid fibril from hereditary amyloidosis.
Karimi-Farsijani S, Sharma K, Ugrina M, Kuhn L, Pfeiffer PB, Haupt C, Wiese S, Hegenbart U, Schönland SO, Schwierz N, Schmidt M, Fändrich M. Karimi-Farsijani S, et al. Among authors: hegenbart u. Nat Commun. 2024 Nov 7;15(1):9648. doi: 10.1038/s41467-024-54091-7. Nat Commun. 2024. PMID: 39511224 Free PMC article.
281 results